Boss Material or Future Product Distribution?
Today HVT was up $0.05 (+6.5%) on 639k shares of volume to close at $0.82. We found out why trading on Harvest One (HVT) was halted yesterday as they announced the appointment of a brand new CEO this morning. Grant Froese spent 38 years with the Canadian grocery giant Loblaws where he ran operations and merchandising at all levels. This could be a great opportunity for Harvest One’s product Dream Water
Harvest One acquired Dream Water in May of this year. It is already a strong revenue generating asset bringing in $6 million per annum, the product sells in 30,000 retail outlets including Shoppers Drug Mart. Harvest One’s plan is to create a CBD infused version; the timeline as to when this will be on the shelves is still unknown. Dream Water is a liquid, non-prescription, fast acting sleep aid that purports to help its users fall asleep and stay asleep longer.
This move today could also be an opportunity for their CBD extract subsidiary Satipharm to get its products into stores down the line as well.
Gene Simmons & Derivatives Totally Go Together
As ‘Chief Evangelist Officer’, Gene Simmons continues to ‘convey the vision’ of Invictus (GENE.V) as they raise 5.8M in options and warrants. A total of 4,346,731 warrants and 337,500 options were exercised for proceeds of $5,267,467 and $509,800, respectively.
The proceeds will go towards expanding their current cultivation spaces. Investors may hope they will put some of these proceeds towards acting classes to make Gene a little more empathetic in his future television interviews. Consumers of entertainment hope he stays on course.
Here are some suggested strains that Invictus could debut for rec ( I want a 3% royalty for future sales of these).
‘Love Gun’ – Your Late Night Solution (high THC, low CBD)
‘Heaven’s On Fire’ – Fight Inflammation (low THC, high CBD)
‘Christine Sixteen’ – Your Teenage Daughter’s First Hit (high THC, low CBD)
‘The Next TGOD’
One of the most talked about stories in the cannabis forums right now continues to be the upcoming Tilray IPO. The Nanaimo based company will be listing on the NASDAQ in the near future. Tilray’s current operations include:
Tilray North America Campus – Nanaimo, British Columbia: 60,000 square foot growing facility.
High Park Processing Facility – London, Ontario: 56,000 square foot processing facility.
Tilray currently have offices in Seattle, Nanaimo, Toronto, Berlin and Sydney. Their production space is estimated to hit 912,000 square feet by the end of 2018.
This opportunity has investors salivating as the company reported revenue of $7.8M CAD with a gross profit of $3.9M CAD in Q1 of 2018. An impressive 50% margin. Tilray has filed to raise $100M USD through its Class 2 stock.
For any swing trader who sat on the sidelines for the TGOD IPO, this could be the opportunity for a little redemption. For the value investors, this company does actually have some pretty impressive numbers to crunch:
– Source Tilray
Next Week On…
Canopy (WEED) put out an interesting late press release at 5PM EST today titled ‘ Media Advisory – Tomorrow will be busy in the Canopy world’. This is regarding a conference call to take place at 1 PM Eastern tomorrow.